Adnexal masses in pregnancy

Onkologie

Volumn 26, Issue 2, 2003, Pages 167-172

  Hermans, R H M ^a   Fischer, D C ^a   Van Der Putten, H W H M ^a   Van De Putte, G ^a   Einzmann, T ^a   Vos, M C ^a   Kieback, Dirk Günther ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Ovarian cancer; Pregnancy; Treatment concepts

Indexed keywords

TUMOR MARKER;

ABORTION; ADNEXA DISEASE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER SURGERY; CORRELATION ANALYSIS; CYST; CYTOLOGY; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; HISTOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANOGENESIS; OVARY CANCER; OVARY TUMOR; PATHOLOGY; PREGNANCY; PREOPERATIVE EVALUATION; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETAL VIABILITY; GESTATIONAL AGE; HUMANS; INCIDENTAL FINDINGS; INFANT, NEWBORN; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; ULTRASONOGRAPHY, PRENATAL;

EID: 0037977111     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069838     Document Type: Review

References (51)

1. Whitecar MP, Turner S, Higby MK: Adnexal masses in pregnancy: A review of 130 cases undergoing surgical management. Am J Obstet Gynecol 1999;181:19-24.
2. Grendys EC, Jr., Barnes WA: Ovarian cancer in pregnancy. Surg Clin North Am 1995;75:1-14.
3. Nelson MJ, Cavalieri R, Graham D, Sanders RC: Cysts in pregnancy discovered by sonography. J Clin Ultrasound 1986;14:509-512.
4. Perkins KY, Johnson JL, Kay HH: Simple ovarian cysts. Clinical features on a first-trimester ultrasound scan. J Reprod Med 1997;42:440-444.
5. Hogston P, Lilford RJ: Ultrasound study of ovarian cysts in pregnancy: Prevalence and significance. Br J Obstet Gynaecol 1986;93:625-628.
6. Bromley B, Benacerraf B: Adnexal masses during pregnancy: Accuracy of sonographic diagnosis and outcome. J Ultrasound Med 1997;16:447-452; quiz 453-454.
7. Woods JB, Blake PG, Perry KG, Jr., Magann EF, Martin RW, Martin JN, Jr.: Ascites: A portent of cardiopulmonary complications in the preeclamptic patient with the syndrome of hemolysis, elevated liver enzymes, and low platelets. Obstet Gynecol 1992;80:87-91.
8. Kier R, McCarthy SM, Scoutt LM, Viscarello RR, Schwartz PE: Pelvic masses in pregnancy: MR imaging. Radiology 1990;176:709-713.
9. Spitzer M, Kaushal N, Benjamin F: Maternal CA-125 levels in pregnancy and the puerperium. J Reprod Med 1998;43:387-392.
10. Cheli CD, Morris DL, Neaman IE, Dai J, Allard WJ, Yeung KK: Measurement of four tumor marker antigens in the sera of pregnant women. J Clin Lab Anal 1999;13:35-39.
11. Robertson DM, Stephenson T, Pruysers E, Burger HG, McCloud P, Tsigos A, Groome N, Mamers P, McNeilage J, Jobling T, Healy D: Inhibins/activins as diagnostic markers for ovarian cancer. Mol Cell Endocrinol 2002;191:97-103.
12. Florio P, Cobellis L, Luisi S, Ciarmela P, Severi FM, Bocchi C, Petraglia F: Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol Cell Endocrinol 2001;180:123-130.
13. Wald NJ, Morris JK: Multiple marker second trimester serum screening for pre-eclampsia. J Med Screen 2001;8:65-68.
14. van Pampus MG, Wolf H, Mayruhu G, Treffers PE, Bleker OP: Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy 2001;20:15-23.
15. Guariglia L, Conte M, Are P, Rosati P: Ultrasound-guided fine needle aspiration of ovarian cysts during pregnancy. Eur J Obstet Gynecol Reprod Biol 1999;82:5-9.
16. Caspi B, Ben-Arie A, Appelman Z, Or Y, Hagay Z: Aspiration of simple pelvic cysts during pregnancy. Gynecol Obstet Invest 2000;49:102-105.
17. Khaw KT, Walker WJ: Ultrasound guided fine needle aspiration of ovarian cysts: Diagnosis and treatment in pregnant and non-pregnant women. Clin Radiol 1990;41:105-108.
18. Martinez-Onsurbe P, Ruiz Villaespesa A, Sanz Anquela JM, Valenzuela Ruiz PL: Aspiration cytology of 147 adnexal cysts with histologic correlation. Acta Cytol 2001;45:941-947.
19. Kindermann G, Maassen V, Kuhn W: Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics. Geburtshilfe Frauenheilkd 1995;55:687-694.
20. Milad MP, Olson E: Factors that increase the risk of leakage during surgical removal of benign cystic teratomas. Hum Reprod 1999;14:2264-2267.
21. Nezhat F, Nezhat C, Silfen SL, Fehnel SH: Laparoscopic ovarian cystectomy during pregnancy. J Laparoendosc Surg 1991;1:161-164.
22. Nezhat FR, Tazuke S, Nezhat CH, Seidman DS, Phillips DR, Nezhat CR: Laparoscopy during pregnancy: A literature review. JSLS 1997;1:17-27.
23. Moore RD, Smith WG: Laparoscopic management of adnexal masses in pregnant women. J Reprod Med 1999;44:97-100.
24. Soriano D, Yefet Y, Seidman DS, Goldenberg M, Mashiach S, Oelsner G: Laparoscopy versus laparotomy in the management of adnexal masses during pregnancy. Fertil Steril 1999;71:955-960.
25. Yuen PM, Chang AM: Laparoscopic management of adnexal mass during pregnancy. Acta Obstet Gynecol Scand 1997;76:173-176.
26. Ueda M, Ueki M: Ovarian tumors associated with pregnancy. Int J Gynaecol Obstet 1996;55:59-65.
27. Beischer NA, Buttery BW, Fortune DW, Macafee CA: Growth and malignancy of ovarian tumours in pregnancy. Aust N Z J Obstet Gynaecol 1971;11:208-220.
28. Karlen JR, Akbari A, Cook WA: Dysgerminoma associated with pregnancy. Obstet Gynecol 1979;53:330-335.
29. Boulay R, Podczaski E: Ovarian cancer complicating pregnancy. Obstet Gynecol Clin North Am 1998;25:385-399.
30. Ebert U, Loffler H, Kirch W: Cytotoxic therapy and pregnancy. Pharmacol Ther 1997;74:207-220.
31. Pirani BB, Campbell DM, MacGillivray I: Plasma volume in normal first pregnancy. J Obstet Gynaecol Br Commonw 1973;80:884-887.
32. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
33. Ozols RF: Future directions in the treatment of ovarian cancer. Semin Oncol 2002;29(suppl 1):32-42.
34. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
35. Somasundaram K: Tumor suppressor p53: Regulation and function. Fronti Biosci 2000;5:D424-437.
36. Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW, Galloway DA: Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nat Med 1996;2:72-79.
37. Nielsen LL, Maneval DC: P53 tumor suppressor gene therapy for cancer. Cancer Gene Ther 1998;5:52-63.
38. Scialli AR, Waterhouse TB, Desesso JM, Rahman A, Goeringer GC: Protective effect of liposome encapsulation on paclitaxel developmental toxicity in the rat. Teratology 1997;56:305-310.
39. Kai S, Kohmura H, Hiraiwa E, Koizumi S, Ishikawa K, Kawano S, Kuroyanagi K, Hattori N, Chikazawa H, Kondoh H, et al.: Reproductive and developmental toxicity studies of paclitaxel. (III) - Intravenous administration to rats during the perinatal and lactation periods. J Toxicol Sci 1994;19 (suppl 1):93-111.
40. Kai S, Kohmura H, Hiraiwa E, Koizumi S, Ishikawa K, Kawano S, Kuroyanagi K, Hattori N, Chikazawa H, Kondoh H, et al.: Reproductive and developmental toxicity studies of paclitaxel. (II) - Intravenous administration to rats during the fetal organogenesis. J Toxicol Sci 1994;19(suppl 1):69-91.
41. Kai S, Kohmura H, Hiraiwa E, Koizumi S, Ishikawa K, Kawano S, Kuroyanagi K, Hattori N, Chikazawa H, Kondoh H, et al.: Reproductive and developmental toxicity studies of paclitaxel. (I) - Intravenous administration to rats prior to and in the early stages of pregnancy. J Toxicol Sci 1994;19 (suppl 1):57-67.
42. Kai S, Kohmura H, Ishikawa K, Takeuchi Y, Ohta S, Kuroyanagi K, Kadota T, Kawano S, Chikazawa H, Kondo H, et al.: Reproduction studies of carboplatin(III) - Intravenous administration to rats during the perinatal and lactation periods. J Toxicol Sci 1988;13(suppl 2):63-81.
43. Kai S, Kohmura H, Ishikawa K, Takeuchi Y, Ohta S, Kuroyanagi K, Kadota T, Kawano S, Chikazawa H, Kondo H, et al.: Reproduction studies of carboplatin (II) - Intravenous administration to rats during the period of fetal organogenesis. J Toxicol Sci 1988;13(suppl 2):35-61.
44. Kai S, Kohmura H, Ishikawa K, Takeuchi Y, Ohta S, Kuroyanagi K, Kadota T, Kawano S, Chikazawa H, Kondo H, et al.: Reproduction studies of carboplatin (I) - Intravenous administration to rats prior to and in the early stages of pregnancy. J Toxicol Sci 1988;13(suppl 2):23-34.
45. Kai S, Kohmura H, Ishikawa K, Makihara Y, Ohta S, Kawano S, Takahashi N: Teratogenic effects of carboplatin, an oncostatic drug, administered during the early organogenetic period in rats. J Toxicol Sci 1989;14:115-130.
46. Sood AK, Shahin MS, Sorosky JI: Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001;83:599-600.
47. Cardonick EH, Stephanuk K, Kaufman M: Cancer diagnosed and treated during pregnancy. Am J Obstet Gynecol 2001;185:S178, abstr 355.
48. Reidenbach F: Chemotherapy safe in pregnancy. Lancet Oncol 2002;3:128.
49. Stedman CM, Kline RC: Intraoperative complications and unexpected pathology at the time of cesarean section. Obstet Gynecol Clin North Am 1988;15:745-769.
50. Novak ER, Lambrou CD, Woodruff JD: Ovarian tumors in pregnancy. An ovarian tumor registry review. Obstet Gynecol 1975;46:401-406.
51. Copeland LJ, Landon MB: Malignant disease in pregnancy, in Gabbe SG, Niebyl JR, Simpson JL (eds): Obstetrics: Normal and Problem Pregnancies. New York, Churchill Livingstone, 1996, pp 1155-1181.